Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis

Journal of Neurochemistry

Volumn 96, Issue 3, 2006, Pages 777-789

  Broccolini, Aldobrando ^a   Gidaro, Teresa ^a   Morosetti, Roberta ^a   Gliubizzi, Carla ^a   Servidei, Tiziana ^a   Pescatori, Mario ^a   Tonali, Pietro A ^a,c   Ricci, Enzo ^a,b   Mirabella, Massimiliano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Unione Italiana Lotta Alla Distrofia Muscolare Rome Section   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Inclusion body myositis; Insulin like growth factor I; Insulin like growth factor binding protein; Muscle differentiation; Neprilysin

Indexed keywords

3 MERCAPTO 2 BENZYLPROPANOYLGLYCINE; AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; PROTEIN INHIBITOR; PROTEIN KINASE B; REGULATOR PROTEIN; SOMATOMEDIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOFIBROBLAST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELLS, CULTURED; CYCLOHEXIMIDE; DESMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; MYOSINS; MYOSITIS, INCLUSION BODY; NEPRILYSIN; ONCOGENE PROTEIN V-AKT; PROTEIN SYNTHESIS INHIBITORS; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIOPHANATE; TIME FACTORS;

EID: 33645100936     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03584.x     Document Type: Article

References (62)

1. Adams GR. 2002 Autocrine and/or paracrine insulin-like growth factor-I activity in skeletal muscle ClinOrthopRelatRes 401 S188 196 q8
2. Akiyama H. Kondo H. Ikeda K. Kato M. McGeer PL. 2001 Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition Brain Res 902 277 281
3. Askanas V. Engel WK. 1992 Cultured normal and genetically abnormal human muscle, in Handbook of Clinical Neurology Rowland LP. Di Mauro S., eds), pp. 85 116 Elsevier Science Publisher Amsterdamq9
4. Askanas V. Engel WK. 2002 Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms CurrOpinNeurol 15 525 531
5. Baldwin TJ. Fazeli MS. Doherty P. Walsh FS. 1996 Elucidation of the molecular actions of NCAM and structurally related cell adhesion molecules JCell Biochem 61 502 513
6. Baxter RC. Meka S. Firth SM. 2002 Molecular distribution of IGF binding protein-5 in human serum JClinEndocrinolMetab 87 271 276
7. Broccolini A. Engel WK. Alvarez RB. Askanas V. 2000 Redox factor-1 in muscle biopsies of patients with inclusion-body myositis NeurosciLett 287 1 4
8. Broccolini A. Ricci E. Pescatori M. Papacci M. Gliubizzi C. D'Amico A. Servidei S. Tonali P. Mirabella M. 2004 Insulin-like growth factor I in inclusion-body myositis and human muscle cultures JNeuropatholExpNeurol 63 650 659
9. Caccamo A. Oddo S. Sugarman MC. Akbari Y. Laferla FM. 2005 Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders NeurobiolAging 26 645 654
10. Carmeli E. Moas M. Reznick AZ. Coleman R. 2004 Matrix metalloproteinases and skeletal muscle: a brief review Muscle Nerve 29 191 197
11. Coolican SA. Samuel DS. Ewton DZ. McWade FJ. Florini JR. 1997 The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways JBiolChem 272 6653 6662
12. Couch CB. Strittmatter WJ. 1983 Rat myoblast fusion requires metalloendoprotease activity Cell 32 257 265
13. Couch CB. Strittmatter WJ. 1984 Specific blockers of myoblast fusion inhibit a soluble and not the membrane-associated metalloendoprotease in myoblasts JBiolChem 259 5396 5399
14. Datta SR. Brunet A. Greenberg ME. 1999 Cellular survival: a play in three Akts Genes Dev 13 2905 2927
15. Devault A. Lazure C. Nault C. et al. 1987 Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA EMBO J 6 1317 1322
16. Florini JR. Ewton DZ. Coolican SA. 1996 Growth hormone and the insulin-like growth factor system in myogenesis EndocrRev 17 481 517
17. Foulstone EJ. Savage PB. Crown AL. Holly JM. Stewart CE. 2003 Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts JCell Physiol 195 70 79
18. Galliano MF. Huet C. Frygelius J. Polgren A. Wewer UM. Engvall E. 2000 Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion JBiolChem 275 13 933 13 939
19. Gomes I. Aumuller G. Wennemuth G. Bette M. Albrecht M. 2003 Independent signals determine the subcellular localization of NEP in prostate cancer cells BiochemBiophysResCommun 310 919 926
20. Heemskerk VH. Daemen MA. Buurman WA. 1999 Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation Cytokine Growth Factor Rev 10 5 14
21. Howell S. Nalbantoglu J. Crine P. 1995 Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism Peptides 16 647 652
22. Iwata N. Tsubuki S. Takaki Y. et al. 2000 Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition NatMed 6 143 150
23. Iwata N. Tsubuki S. Takaki Y. Shirotani K. Lu B. Gerard NP. Gerard C. Hama E. Lee HJ. Saido TC. 2001 Metabolic regulation of brain Abeta by neprilysin Science 292 1550 1552
24. Iwata N. Mizukami H. Shirotani K. Takaki Y. Muramatsu S. Lu B. Gerard NP. Gerard C. Ozawa K. Saido TC. 2004 Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain JNeurosci 24 991 998
25. James PL. Stewart CE. Rotwein P. 1996 Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism JCell Biol 133 683 693
26. Jiang BH. Aoki M. Zheng JZ. Li J. Vogt PK. 1999 Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B ProcNatl AcadSciUSA 96 2077 2081
27. Kanemitsu H. Tomiyama T. Mori H. 2003 Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form NeurosciLett 350 113 116
28. Kerr MA. Kenny AJ. 1974 The purification and specificity of a neutral endopeptidase from rabbit kidney brush border BiochemJ 137 477 488
29. Kiryu-Seo S. Sasaki M. Yokohama H. Nakagomi S. Hirayama T. Aoki S. Wada K. Kiyama H. 2000 Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers ProcNatl AcadSciUSA 97 4345 4350
30. Kitzmann M. Vandromme M. Schaeffer V. Carnac G. Labbe JC. Lamb N. Fernandez A. 1999 cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity MolCell Biol 19 3167 3176
31. Lafrance MH. Vezina C. Wang Q. Boileau G. Crine P. Lemay G. 1994 Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11 BiochemJ 302 451 454
32. Lafuste P. Sonnet C. Chazaud B. Dreyfus PA. Gherardi RK. Wewer UM. Authier FJ. 2005 ADAM12 and {alpha}9{beta}1 integrin are instrumental in human myogenic cell differentiation MolBiolCell 16 861 870
33. Laporte J. D'Orleans-Juste P. Sirois P. 1996 Guinea pig Clara cells secrete endothelin 1 through a phosphoramidon-sensitive pathway AmJRespirCell MolBiol 14 356 362
34. Leissring MA. Farris W. Chang AY. Walsh DM. Wu X. Sun X. Frosch MP. Selkoe DJ. 2003 Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 1087 1093
35. Lindon C. Montarras D. Pinset C. 1998 Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts JCell Biol 140 111 118
36. Lorkowski G. Zijderhand-Bleekemolen JE. Erdos EG. von Figura K. Hasilik A. 1987 Neutral endopeptidase-24.11 (enkephalinase). Biosynthesis and localization in human fibroblasts BiochemJ 248 345 350
37. Lu B. Gerard NP. Kolakowski LF. Jr. Bozza M. Zurakowski D. Finco O. Carroll MC. Gerard C. 1995 Neutral endopeptidase modulation of septic shock JExpMed 181 2271 2275
38. Marr RA. Guan H. Rockenstein E. Kindy M. Gage FH. Verma I. Masliah E. Hersh LB. 2004 Neprilysin regulates amyloid Beta peptide levels JMolNeurosci 22 5 11
39. Mirabella M. Alvarez RB. Bilak M. Engel WK. Askanas V. 1996a Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies JNeuropatholExpNeurol 55 774 786 q10
40. Mirabella M. Alvarez RB. Engel WK. Weisgraber KH. Askanas V. 1996b Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies AnnNeurol 40 864 872 q11
41. Musaro A. Rosenthal N. 1999 Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I MolCell Biol 19 3115 3124
42. Nam TJ. Busby WH. Jr. Clemmons DR. 1996 Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts Endocrinology 137 5530 5536
43. Papandreou CN. Usmani B. Geng Y. et al. 1998 Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression NatMed 4 50 57
44. Rawlings ND. Tolle DP. Barrett AJ. 2004 MEROPS: the peptidase database NuclAcids Res 32 D160 D164
45. Roques BP. Fournie-Zaluski MC. Soroca E. Lecomte JM. Malfroy B. Llorens C. Schwartz JC. 1980 The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice Nature 288 286 288
46. Russell JS. Chi H. Lantry LE. Stephens RE. Ward PE. 1996 Substance P and neurokinin A metabolism by cultured human skeletal muscle myocytes and fibroblasts Peptides 17 1397 1403
47. Salih DA. Tripathi G. Holding C. Szestak TA. Gonzalez MI. Carter EJ. Cobb LJ. Eisemann JE. Pell JM. 2004 Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice ProcNatl AcadSciUSA 101 4314 4319
48. Sarkozi E. Askanas V. Engel WK. 1994a Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy AmJPathol 145 1280 1284 q12
49. Sarkozi E. Askanas V. Johnson SA. McFerrin J. Engel WK. 1994b Expression of beta-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro ExpNeurol 128 27 33 q13
50. Shiiki T. Ohtsuki S. Kurihara A. Naganuma H. Nishimura K. Tachikawa M. Hosoya K. Terasaki T. 2004 Brain insulin impairs amyloid-beta(1-40) clearance from the brain JNeurosci 24 9632 9637
51. Shirotani K. Tsubuki S. Iwata N. et al. 2001 Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases JBiolChem 276 21 895 21 901
52. Sumitomo M. Shen R. Walburg M. et al. 2000 Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling JClinInvest 106 1399 1407
53. Sumitomo M. Iwase A. Zheng R. Navarro D. Kaminetzky D. Shen R. Georgescu MM. Nanus DM. 2004 Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN Cancer Cell 5 67 78
54. Thrailkill KM. Quarles LD. Nagase H. Suzuki K. Serra DM. Fowlkes JL. 1995 Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation Endocrinology 136 3527 3533
55. Tiffin N. Adi S. Stokoe D. Wu NY. Rosenthal SM. 2004 Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation Endocrinology 145 4991 4996
56. Turner AJ. Isaac RE. Coates D. 2001 The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function Bioessays 23 261 269
57. Vaghy PL. Russell JS. Lantry LE. Stephens RE. Ward PE. 1995 Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts Peptides 16 1367 1373
58. Wilczak N. de Vos RA. De Keyser J. 2003 Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis Lancet 361 1007 1011
59. Winter A. Bornemann A. 1999 NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases NeuropatholApplNeurobiol 25 417 424
60. Xu Q. Wu Z. 2000 The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells JBiolChem 275 36 750 36 757
61. Yagami-Hiromasa T. Sato T. Kurisaki T. Kamijo K. Nabeshima Y. Fujisawa-Sehara A. 1995 A metalloprotease-disintegrin participating in myoblast fusion Nature 377 652 656
62. Yasojima K. Akiyama H. McGeer EG. McGeer PL. 2001 Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide NeurosciLett 297 97 100